Strong Balance Sheet Stocks

Results

3577

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

3577 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	RADA	US$9.87	-2.4%	5.0%	US$490.9m	US$14.00	85.0	83.7%	n/a	Capital Goods
	FFHL	US$8.30	0.7%	8.1%	US$27.1m	n/a	2.8	n/a	n/a	Materials
	PBIP	US$15.13	-0.7%	9.6%	US$117.7m	US$15.00	1.0	87.9%	1.9%	Banks
	BKFG	US$94.00	0%	n/a	US$54.8m	n/a	6.8	n/a	n/a	Diversified Financials
	KANP	US$30.01	-3.2%	n/a	US$55.4m	n/a	5.1	n/a	n/a	Real Estate Management and Development
	FRAF	US$63.21	2.9%	83.3%	US$284.0m	US$64.00	1.6	11.2%	2.2%	Banks
	ERIE	US$238.71	7.9%	-29.9%	US$12.5b	n/a	21.8	n/a	2.5%	Insurance
	WBHC	US$1,500.00	0%	900.0%	US$18.4b	n/a	31.0	n/a	0.2%	Banks
	URBN	US$73.54	-3.8%	6.0%	US$6.3b	US$84.00	13.3	6.4%	n/a	Retail
	HYFT	US$1.58	3.3%	42.3%	US$78.5m	US$4.33	4.0	46.7%	n/a	Pharmaceuticals & Biotech
	SRCE	US$81.96	6.6%	32.5%	US$2.0b	US$79.67	1.5	3.4%	2.1%	Banks
	YQ	US$2.30	2.6%	-0.6%	US$24.9m	n/a	0.9	n/a	n/a	Consumer Services
	EXPD	US$160.73	-0.4%	39.8%	US$21.0b	US$147.54	25.1	4.1%	1.0%	Transportation
	ELMA	US$25.50	2.6%	21.4%	US$29.4m	n/a	0.7	n/a	2.4%	Banks
	VTEX	US$4.04	11.9%	-37.5%	US$688.8m	US$6.01	29.7	24.3%	n/a	Software
	ACAD	US$25.32	17.1%	14.5%	US$4.3b	US$32.00	11.5	11.8%	n/a	Pharmaceuticals & Biotech
	VYGR	US$3.59	-3.5%	21.3%	US$216.9m	US$14.89	5.9	-4.8%	n/a	Pharmaceuticals & Biotech
	ANF	US$91.51	4.9%	10.6%	US$4.1b	US$111.30	8.2	0.9%	0%	Retail
	FSBW	US$43.22	3.7%	9.6%	US$229.6m	US$46.00	0.7	12.8%	2.7%	Banks
	MYRG	US$477.95	3.7%	161.7%	US$7.4b	US$455.00	52.4	16.3%	n/a	Capital Goods
	INSP	US$45.72	7.3%	-65.5%	US$1.3b	US$50.92	10.0	-14.0%	n/a	Healthcare
	BBSI	US$36.06	9.1%	-13.9%	US$885.6m	US$42.25	21.8	21.3%	0.9%	Commercial Services
	NGLD	US$0.39	-11.0%	-60.3%	US$11.2m	n/a	1.6	n/a	n/a	Materials
	TNYA	US$0.72	-1.8%	17.7%	US$155.7m	US$4.00	692.0	60.9%	n/a	Pharmaceuticals & Biotech

Page 1 of 100